arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Strata Critical Medical, Inc.

SRTA
$5.25 ▲ +0.02 (+0.38%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
28 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Bullish
auto_awesome

Analytical Summary

Strata Critical Medical, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $463.4M
Dividend Yield —
Revenue Growth 50.3% ↗
Op. Margin -5.2% ↗
ROIC -1.4% ↗
FCF / Share $0.10 ↗
Trailing P/E —
Price / Book 1.7x
FCF Yield 2.0%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$74.08M
↑ +50.3% —
Net Income Profit after all expenses
$-7.62M
↑ +27.6% —
Operating Margin Operating profit as % of sales
-5.2%
↑ +30.7% 14th
FCF / Share Free cash flow per share
$0.10
↑ +176.7% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
34
Returns
80
Cash Quality
8

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 28 quarters